FTB Advisors Inc. grew its holdings in Express Scripts Holding Co (NASDAQ:ESRX) by 38.9% during the second quarter, HoldingsChannel.com reports. The firm owned 5,139 shares of the company’s stock after buying an additional 1,438 shares during the period. FTB Advisors Inc.’s holdings in Express Scripts were worth $396,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the company. Toronto Dominion Bank increased its holdings in shares of Express Scripts by 18.7% in the 2nd quarter. Toronto Dominion Bank now owns 362,499 shares of the company’s stock valued at $27,983,000 after purchasing an additional 57,013 shares during the period. Sivik Global Healthcare LLC acquired a new position in shares of Express Scripts in the 2nd quarter valued at about $3,861,000. Carnick & Kubik Group LLC increased its holdings in Express Scripts by 14.2% in the second quarter. Carnick & Kubik Group LLC now owns 45,599 shares of the company’s stock worth $3,521,000 after buying an additional 5,654 shares during the last quarter. Morningstar Investment Services LLC increased its holdings in Express Scripts by 1.3% in the second quarter. Morningstar Investment Services LLC now owns 455,010 shares of the company’s stock worth $35,131,000 after buying an additional 5,872 shares during the last quarter. Finally, Wedbush Securities Inc. increased its holdings in Express Scripts by 49.4% in the second quarter. Wedbush Securities Inc. now owns 10,398 shares of the company’s stock worth $803,000 after buying an additional 3,437 shares during the last quarter. Institutional investors own 84.52% of the company’s stock.
ESRX has been the topic of a number of research reports. BidaskClub downgraded Express Scripts from a “hold” rating to a “sell” rating in a report on Saturday, July 21st. ValuEngine downgraded Express Scripts from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. Zacks Investment Research downgraded Express Scripts from a “hold” rating to a “sell” rating in a report on Tuesday, May 1st. Robert W. Baird set a $92.00 price objective on Express Scripts and gave the stock a “buy” rating in a report on Thursday, May 17th. Finally, Leerink Swann dropped their price objective on Express Scripts from $90.00 to $80.00 and set a “market perform” rating on the stock in a report on Thursday, May 3rd. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $83.58.
Express Scripts (NASDAQ:ESRX) last announced its earnings results on Wednesday, August 1st. The company reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.20 by $0.02. The firm had revenue of $25.64 billion during the quarter, compared to analysts’ expectations of $25.43 billion. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The company’s revenue was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.73 earnings per share. equities analysts predict that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.
In other Express Scripts news, insider Christine Houston sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 13th. The stock was sold at an average price of $82.28, for a total transaction of $822,800.00. Following the completion of the sale, the insider now owns 108,010 shares of the company’s stock, valued at $8,887,062.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.79% of the stock is owned by corporate insiders.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.